Outcome of Board Meeting

ORTIN GLOBAL LIMITED (Formerly Known as ORTIN LABORATORIES LIMITED) CIN: L68200TG1986PLC006885 To Date: 07.09.2026 1. BSE Limited, 2. National Stock Exchange of India Limited P.J. Towers, Dalal Street, Exchange Plaza, Bandra- Kurla Complex, Mumbai-400001 Mumbai 400051 Scrip Code: 539287 Symbol: ORTINGLOBE Dear Sir/Madam, Sub: Outcome of Board Meeting held on 07.09.2026 Unit: Ortin Global Limited With reference to the subject cited, this is to inform the Exchanges that at the meeting of the Board of Directors of Ortin Global Limited held on Monday, 07.09.2026 at 05:30 p.m. at the Registered Office of the Company at D. No. 1-8-305, Ground Floor, Chikkadpally, Musheerabad (Delivery), Hyderabad-500020, Telangana, the following items were inter-alia considered and approved: 1. Change in designation of Mr. Murali Krishna Murthy Sanka (DIN: 00540632) from Managing Director to Non-Executive Director of the company w.e.f. 07.09.2026, subject to the approval of the members. 2. Change in designation of Mr. Prakash Prashanth Sawant (DIN: 11128335) from Whole-time Director to Managing Director of the company for a period of three years w.e.f. 07.09.2026 up to 06.09.2029, subject to the approval of the members. 3. Resignation of Mrs. Prakruti Prashant Sawant (DIN: 11162997) from the post of Whole-time Director of the company w.e.f. 07.09.2026, due to professional commitments. (Resignation letter is enclosed) 4. Appointment of Mr. Parveen Satija (DIN: 00197648) as an Additional Director and Whole-time Director in of the company for a period of 2 years w.e.f. 07.09.2026 up to 06.09.2028, subject to the approval of the members of the company. (Brief profile is attached) 5. 39th Directors Report for the Financial year 2025-26 and notice for convening 39th Annual General Meeting (AGM) for the Financial Year 2025-26. 6. 39th Annual General meeting for the FY 2025-26 is scheduled to be held on Wednesday, 30th September,2026 at 5:00 p.m. through video Conference or Other Audio-visual means (OAVM). Regd. Office: D. No. 1-8-305, Ground Floor, Chikkadpally, Musheerabad (Delivery), Hyderabad-500020, Telangana, India. Email:info@ortinlabsindia.com Website:www.ortinlabsindia.com Ph. No. +91 9052011118 ORTIN GLOBAL LIMITED (Formerly Known as ORTIN LABORATORIES LIMITED) CIN: L68200TG1986PLC006885 The meeting concluded at 07:00 p.m. We request you to take note of the same in your records Thanking you. Yours sincerely, For Ortin Global Limited S. Murali Krishna Murthy Director (DIN:00540632) Regd. Office: D. No. 1-8-305, Ground Floor, Chikkadpally, Musheerabad (Delivery), Hyderabad-500020, Telangana, India. Email:info@ortinlabsindia.com Website:www.ortinlabsindia.com Ph. No. +91 9052011118 ORTIN GLOBAL LIMITED (Formerly Known as ORTIN LABORATORIES LIMITED) CIN: L68200TG1986PLC006885 ANNEXURE-A Details as required under Part A of Schedule III and Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No: SEBI/HO/CFD/PoD2/CIR/P/0155 dated January 30, 2026, concerning the appointments and resignation is provided below: S.No Particulars Mr. Parveen Satija Mrs. Prakruti Prashant Sawant 1. Reason for Change viz. Appointment of Mr. Parveen Satija Mrs. Prakruti Prashant appointment, as an Additional Director and Sawant has resigned from reappointment, Whole-time Director of the the position of Whole-time resignation, removal, company Director of the company due death or otherwise to her professional commitments. 2. Date of Appointment / Appointed on 07.09.2026 Resigned from close of Cessation business hours on 07.09.2026 3. Terms of appointment 2 years NA 4. Brief profile (in case of Mr. Parveen Satija is an Indian NA appointment) business professional with experience in corporate leadership and management. He has served as a Director in private limited companies and has experience in corporate governance, board-level oversight, statutory and regulatory compliance and strategic supervision of business operations. He has been associated with privately held enterprises and possesses exposure to trading and commercial activities, business operations and stakeholder coordination. 5. Disclosure of Nil NA Relationships with other Directors (in case of appointment) 6. Shareholding, if any in 1,00,526 Equity Shares NA the company 7. Affirmation that the To the best of our knowledge and NA Director being appointed information, we hereby affirm that is not debarred from Mr. Parveen Satija is not debarred Regd. Office: D. No. 1-8-305, Ground Floor, Chikkadpally, Musheerabad (Delivery), Hyderabad-500020, Telangana, India. Email:info@ortinlabsindia.com Website:www.ortinlabsindia.com Ph. No. +91 9052011118 ORTIN GLOBAL LIMITED (Formerly Known as ORTIN LABORATORIES LIMITED) CIN: L68200TG1986PLC006885 holding the office of from holding the office of Director director by virtue of any by virtue of any SEBI order or any SEBI order or any other other such authority such authority 8. Name of listed entities in NA Nil which the resigning Director holds directorship S.No Particulars Mr. Murali Krishna Murthy Sanka Mr. Prashanth Prakash Sawant 1. Reason for Change viz. Change in designation of Mr. Change in designation of appointment, Murali Krishna Murthy Sanka Mr. Prashanth Prakash reappointment, from Managing Director to Non- Sawant from Whole-time resignation, removal, Executive Director Director to Managing death or otherwise Director 2. Date of Appointment / 07.09.2026 07.09.2026 Cessation 3. Terms of appointment NA 3 years 4. Brief profile (in case of Mr. Murali Krishna Murthy Sanka Mr. Prashant Prakash appointment) started a Pharma. Distribution Sawant is an Ex-vice Business in the year 1978 along President of JP Morgan with his other partners with a very Chase. He is a one of the meager investment. He has leading names in Technical developed the business of the firm Analysis and has been to multi folds within a span of 10 associated with many yrs. He has graduated in Science Pharma as well as Chemical from Nagarjuna University. He has companies, trading in an experience of 37 years in commodities is also his Pharma Business forte. He has a strong understanding of the domestic as well as international commodities market 5. Disclosure of NA NA Relationships with other Directors (in case of appointment) 6. Shareholding, if any in 17,844 Equity Shares NA the company Regd. Office: D. No. 1-8-305, Ground Floor, Chikkadpally, Musheerabad (Delivery), Hyderabad-500020, Telangana, India. Email:info@ortinlabsindia.com Website:www.ortinlabsindia.com Ph. No. +91 9052011118 ORTIN GLOBAL LIMITED (Formerly Known as ORTIN LABORATORIES LIMITED) CIN: L68200TG1986PLC006885 7. Affirmation that the To the best of our knowledge and To the best of our Director being appointed information, we hereby affirm that knowledge and information, is not debarred from Mr. Murali Krishna Murthy Sanka we hereby affirm that holding the office of is not debarred from holding the Mr. Prashant Prakash director by virtue of any office of Director by virtue of any Sawant is not debarred from SEBI order or any other SEBI order or any other such holding the office of such authority authority Director by virtue of any SEBI order or any other such authority 8. Name of listed entities in NA NA which the resigning Director holds directorship Regd. Office: D. No. 1-8-305, Ground Floor, Chikkadpally, Musheerabad (Delivery), Hyderabad-500020, Telangana, India. Email:info@ortinlabsindia.com Website:www.ortinlabsindia.com Ph. No. +91 9052011118